Aytu BioPharma Inc (NASDAQ: AYTU) on Monday, soared 3.81% from the previous trading day, before settling in for the closing price of $2.1. Within the past 52 weeks, AYTU’s price has moved between $0.95 and $2.96.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 66.68% over the last five years. The company achieved an average annual earnings per share of 108.04%. With a float of $5.40 million, this company’s outstanding shares have now reached $6.17 million.
The firm has a total of 102 workers. Let’s measure their productivity. In terms of profitability, gross margin is 68.59%, operating margin of -5.57%, and the pretax margin is 2.57%.
Aytu BioPharma Inc (AYTU) Breakdown of a Key Holders of the stock
Observing investor behavior towards Drug Manufacturers – Specialty & Generic industry stocks is more important than anything else. The insider ownership of Aytu BioPharma Inc is 12.52%, while institutional ownership is 39.71%. The most recent insider transaction that took place on Jun 09 ’25, was worth 24,999. In this transaction Chief Business Officer of this company bought 16,666 shares at a rate of $1.50, taking the stock ownership to the 29,462 shares. Before that another transaction happened on Jun 09 ’25, when Company’s Chief Executive Officer bought 66,666 for $1.50, making the entire transaction worth $99,999. This insider now owns 153,257 shares in total.
Aytu BioPharma Inc (AYTU) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.3 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 108.04% per share during the next fiscal year.
Aytu BioPharma Inc (NASDAQ: AYTU) Trading Performance Indicators
Aytu BioPharma Inc (AYTU) is currently performing well based on its current performance indicators. A quick ratio of 0.87 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.19.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.71, a number that is poised to hit -0.02 in the next quarter and is forecasted to reach -0.15 in one year’s time.
Technical Analysis of Aytu BioPharma Inc (AYTU)
Analysing the last 5-days average volume posted by the [Aytu BioPharma Inc, AYTU], we can find that recorded value of 0.33 million was lower than the volume posted last year of 0.74 million. As of the previous 9 days, the stock’s Stochastic %D was 69.85%.
During the past 100 days, Aytu BioPharma Inc’s (AYTU) raw stochastic average was set at 70.29%, which indicates a significant increase from 56.86% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 42.25% in the past 14 days, which was lower than the 133.68% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.67, while its 200-day Moving Average is $1.68. Now, the first resistance to watch is $2.36. This is followed by the second major resistance level at $2.53. The third major resistance level sits at $2.67. If the price goes on to break the first support level at $2.05, it is likely to go to the next support level at $1.91. Now, if the price goes above the second support level, the third support stands at $1.74.
Aytu BioPharma Inc (NASDAQ: AYTU) Key Stats
Market capitalization of the company is 13.45 million based on 8,977K outstanding shares. Right now, sales total 81,000 K and income totals -15,840 K. The company made 18,450 K in profit during its latest quarter, and 3,990 K in sales during its previous quarter.
